Episoder
-
Manglende episoder?
-
April is National Donate Life Month, and during this time, we focus on raising awareness about transplantation and donation honor the people who have saved lives through the gift of donation. Tune in for this special episode today for an update on the latest in transplant medicine. Transplantation is the best method of treatment for many people with end stage kidney disease, when available and accessible. As a company, we prioritize expanding access to kidney transplantation and work to reduce the challenges facing patients as they work towards getting transplanted.
-
FreseniusRx, the pharmacy business division of Fresenius Medical Care North America, is expanding its services beyond just kidney care to include non-renal medications and will become a go-to pharmacy for our patients’ medications needs. Senior Director of Pharmacy Michelle Nguyen, PharmD, joins Field Notes to explain how this will work and why it is so important to ensure successful medical management and adherence.
-
Optimal starts can result in fewer complications, reduce costs, and improve outcomes for patients. They are considered a key metric for success in many value-based care models. Dr. Murat Sor, Chief Medical Officer for Azura Vascular Care, joins Field Notes to explain how percutaneous procedures can result in optimal starts for patients.
-
With the ambitious goal of enrolling more than 100,000 participants within five years, the My Reason campaign aims to build the largest kidney-focused genomics registry of its kind. Dr. Michael Anger, Principal Investigator for the My Reason Genomics and Precision Medicine Initiative, and Jeffrey Carr, Head of Genomics and Precision Medicine, join Field Notes to discuss the significant impact My Reason will have on improving outcomes for kidney disease patients.
-
According to the Department of Health and Human Services, more than 52.7 million virtual telehealth visits were performed by the end of 2021 due to the COVID-19 pandemic. Will telehealth maintain the same pace even as the pandemic slows down? What have we learned about connected health because of COVID-19 and how will the technology change? Dr. Shelly Nash, Chief Medical Information Officer for Fresenius Medical Care, answers these questions and more on Field Notes.
-
Making organs more accessible and available to patients in need is critical to successful transplants. Casey Humphries, Logistical Products Service Line Leader for the United Network for Organ Sharing (UNOS), joins Field Notes to discuss how the non-profit network was able to help improve organ tracking, shipment, and transplantation through ground-breaking findings on cold ischemic time and UNOS-developed travel applications for organs through a grant from the Fresenius Medical Care Foundation.
-
Comprehensive Kidney Care Contracting, a new value based care initiative in 2022 by the Centers for Medicare and Medicaid Services, aims to improve outcome and reduce costs by assisting patients with kidney disease prior to the need for renal replacement therapy. Dr. Terry Ketchersid, Chief Medical Officer for the Integrated Care Group at Fresenius Medical Care North America, and the co-CMO for InterWell Health, and David Pollack, President of the Integrated Care Group, join to discuss the new program.
- Vis mere
